Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations

Autor: Criswell, Lindsey, Wang, C, Ahlford, A, Järvinen, TM, Nordmark, G, Eloranta, ML, Gunnarsson, I, Svenungsson, E, Padyukov, L, Sturfelt, G, Jönsen, A

Publikováno v: Criswell, Lindsey; Wang, C; Ahlford, A; Järvinen, TM; Nordmark, G; Eloranta, ML; et al.(2013). Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4232g8rs

Recent genome-wide association studies (GWASs) conducted in Asian populations have identified novel risk loci for systemic lupus erythematosus (SLE). Here, we genotyped 10 single-nucleotide polymorphisms (SNPs) in eight such loci and investigated the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::77e89da8c703dca50168d99ce7ee5312
http://www.escholarship.org/uc/item/4232g8rs

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013.

Autor: Remes K; Turku University Hospital and University of Turku, Dept of Clinical Hematology, Turku, Finland., Anttila P; University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Silvennoinen R; Department of Medicine, Kuopio University Hospital, Kuopio, Finland., Putkonen M; Turku University Hospital and University of Turku, Dept of Clinical Hematology, Turku, Finland., Ollikainen H; Satakunta Central Hospital, Pori, Finland., Terävä V; Päijät-Hämeen Central Hospital, Lahti, Finland., Sinisalo M; Department of Internal Medicine, Tampere University Hospital, Tampere, Finland., Kananen K; Kainuu Joint Authority for Social and Health Care, Clinic of Internal Medicine, Kajaani, Finland., Schain F; Janssen Cilag AB, Solna, Sweden., Castren-Kortegangas P; Janssen Cilag OY, Espoo, Finland., Järvinen TM; Janssen Cilag OY, Espoo, Finland., Pisini M; Janssen Cilag NV, Beerse, Belgium., Wahl F; Department of Mathematics, Stockholm University, SE, Stockholm, Sweden., Dixon T; JB Medical Ltd, The Old Brickworks, Sudbury, Suffolk, United Kingdom., Leval A; Janssen Cilag AB, Solna, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Instutitet, Stockholm, Sweden.

Publikováno v: PloS one [PLoS One] 2018 Dec 05; Vol. 13 (12), pp. e0208507. Date of Electronic Publication: 2018 Dec 05 (Print Publication: 2018).

Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia.

Autor: Kämpjärvi K; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland., Järvinen TM; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA., Heikkinen T; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland., Ruppert AS; Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA., Senter L; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA., Hoag KW; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA., Dufva O; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland., Kontro M; Hematology Research Unit Helsinki, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland., Rassenti L; Moores University of California-San Diego Cancer Center, University of California San Diego, CA, USA., Hertlein E; Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA., Kipps TJ; Moores University of California-San Diego Cancer Center, University of California San Diego, CA, USA., Porkka K; Hematology Research Unit Helsinki, Department of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland., Byrd JC; Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA., de la Chapelle A; Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at The Ohio State University, Columbus, OH, USA., Vahteristo P; Department of Medical Genetics and Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland.

Publikováno v: Oncotarget [Oncotarget] 2015 Jan 30; Vol. 6 (3), pp. 1884-8.

Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.

Autor: Taylor, Krystyna¹ (AUTHOR), Pearson, Matthew¹ (AUTHOR), Das, Sayoni¹ (AUTHOR), Sardell, Jason¹ (AUTHOR), Chocian, Karolina¹ (AUTHOR), Gardner, Steve¹ (AUTHOR) steve@precisionlife.com

Publikováno v: Journal of Translational Medicine. 11/1/2023, Vol. 21 Issue 1, p1-23. 23p.

Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.

Autor: Järvinen TM; Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7-9, S-14183 Huddinge, Sweden., Hellquist A, Zucchelli M, Koskenmies S, Panelius J, Hasan T, Julkunen H, D'Amato M, Kere J

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2012 Jan; Vol. 51 (1), pp. 87-92. Date of Electronic Publication: 2011 Oct 27.